Clinical Trial Update: UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating UCMSC-Exo (umbilical cord mesenchymal stem cell-derived exosomes) to address chemotherapy-induced myelosuppression in patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Anemia
• Bleeding
• Infections
• Neutropenia
• Thrombocytopenia

Drugs mentioned

• UCMSC-Exo (umbilical cord mesenchymal stem cell-derived exosome)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Acute Myeloid Leukemia, Neutropenia | Phase 1 | Status: RECRUITING